Skip to content

Neopenda

Wearable vital signs monitor for sick newborns

Raised to date

$35K

of $1.5M offered across 1 Form D filing

Still open
$1.5M
Investors
1
Last filed
May 7, 2026

About

Neopenda is a Chicago-based medical technology company that designs affordable medical equipment for resource-limited healthcare settings. Its flagship product, neoGuard, is a wearable vital signs monitor that continuously tracks pulse rate, respiratory rate, blood oxygen saturation and temperature in critically ill newborns and streams the data wirelessly from multiple infants to a single tablet. The company was founded by biomedical engineers Sona Shah and Teresa Cauvel, who met as graduate students at Columbia University, and has deployed and studied the device in hospitals in East Africa.

Rather than adapting conventional hospital monitors, Neopenda engineers its devices around the constraints of low-resource facilities — unstable power, limited internet, tight space and scarce spare parts — at a price point those hospitals can afford.

Funding

  • DebtFiled May 7, 2026Form D
    $35K/ $1.5M

Product

neoGuard

Patient monitoring device

A rechargeable wearable vital signs monitor for newborns that continuously measures four vital signs and transmits readings wirelessly from many infants to one tablet, alerting nurses when a patient is in distress.

  • Continuous monitoring of pulse rate, respiratory rate, blood oxygen saturation and temperature
  • Wireless streaming from multiple infants to a single tablet dashboard
  • Alerts nurses when a patient's vitals indicate distress

Built for

Hospitals and neonatal units in low-resource and emerging-market healthcare systems

People on file